Primary drug resistance to anti-tuberculous drugs in Karachi

Journal of the College of Physicians and Surgeons Pakistan

Volumn 18, Issue 11, 2008, Pages 699-702

  Javaid, Arshad ^a,g   Rizvi, Nadim ^b   Ansari, Mosavir ^c   Sadiq, Ashraf ^d   Burki, Iqbal Sher ^e   Rehman, Nadeem Ur ^f   Hasan, Rumina ^f   Zafar, Afia ^f  

^a Postgraduate Medical Institute   (Pakistan)

^b Jinnah Postgraduate Medical Centre   (Pakistan)

^c CIVIL HOSPITAL   (Pakistan)

^d Department of Chest Diseases   (Pakistan)

^e Lyari General Hospital   (Pakistan)

^f AGA KHAN UNIVERSITY HOSPITAL   (Pakistan)

^g NONE   (Pakistan)

Author keywords

Mycobacterium tuberculosis (MTB); Primary drug resistance; Pulmonary tuberculosis (PTB)

Indexed keywords

ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATION; CROSS-SECTIONAL STUDY; DRUG EFFICACY; HUMAN; LUNG TUBERCULOSIS; MULTIDRUG RESISTANCE; NONHUMAN; PAKISTAN; SPUTUM ANALYSIS; SPUTUM SMEAR;

ANTITUBERCULAR AGENTS; CROSS-SECTIONAL STUDIES; DISEASE SUSCEPTIBILITY; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; MYCOBACTERIUM TUBERCULOSIS; PAKISTAN; TUBERCULOSIS, MULTIDRUG-RESISTANT; TUBERCULOSIS, PULMONARY;

EID: 57549107312     PISSN: 1022386X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Dye C, Scheele S, Dolin P, Pathania V, Raviglione MC. Consensus statement. Global burden to tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance Monitoring Project. JAMA 1999; 282:677-86.
2. Global tuberculosis control. WHO report 2001. Communicable diseases. Geneva: World Health Organization, 2001.
3. Aziz MA., Wright A, Laszlo A, De Muyvick A, Portaels F, Van Deun A, et al. Epidemiology of anti-tuberculosis (the global Project on anti-tuberculosis drug resistance surveillance): an updated analysis. Lacnet 2006; 368:2142-54.
4. Pablos-Mandez A, Raviglione MC, Laszlo A, Binkin N, Rieder HL, Bustreo F, et al. Global surveillance for anti-tuberculosis drug resistance 1994-97. World Health organization-International Union against tuberculosis and lung diseases Working Group on anti-tuberculosis drug resistance surveillance. N Engl J Med 1998; 338:1641-9.
5. Espinal MA, Laszlo A, Simonsen L, Baulahbal F, King SJ, Reniero A, et al. Global trends in resistance to anti-tuberculosis drugs. World Health Organization-International Union Against Tuberculosis and Lung Disease Working Group on anti-tuberculosis drug resistance surveillance. N Engl J Med 2001; 344:1294-303.
6. Global tuberculosis control - surveillance, planning, financing. WHO report 2007. Geneva: World Health Organization; 2007.
7. Kochi A, Vareldzis B, Styblo K. Multi-drug resistant tuberculosis and its control. Res Microbiol 1993; 144:104-10.
8. Kim SJ, Hong YP. Drug resistance of mycobacterium tuberculosis in Korea. Tuber Lung Dis 1992; 73:219-24.
9. Chandrasekaran S, Jagota P, Chaudhury K. Initial drug resistance to anti-tuberculosis drugs in urban and rural districts tuberculosis programme, Indian J Tuber 1992; 39:171-5.
10. Frieden TR, sterling T, Pabloz-Mendez A, Kilbum JO, Cauthen GM, Dooley SW, et al. The emergence of drug resistance tuberculosis in New York city. N Engl J Med 1993; 328: 521-6.
11. Van der Werf TS, Groothuis DG, Van Klingeren B. High initial drug resistance in pulmonary tuberculosis in Ghana. Tuber Lung Dis 1989; 70: 249-55.
12. Braun MM, Kilburn JO, Smithwick RW, Coulibaly IM, Coulibaly O, Silcox VA, et al. HIV infection and primary resistance to anti-tuberculosis drugs in Abidjan, Cote d' Ivoire. AIDS 1992; 6: 1327-30.
13. Paramasivan CN, Venkataraman P, Bhaskaran K. An overview of drug resistance tuberculosis in India. Indian J Tuber 1998; 45:73.
14. Chode TM. The role of bacteriological surveys in the National Tuberculosis and Leprosy programme in Tanzania. Bull Int Union Tuber Lung Dis 1989; 15.
15. Weyer K, Kleeberg HH. Primary and acquired drug resistance in adult black patients with tuberculosis in South Africa: results of continuous drug resistance surveillance programme involvement. Tuber Lung Dis 1992; 73:106-12.
16. Paramasivan CN, Bhaskaraia K, Venkartaraman P, Chandrase Karan Vand Narayanan PR. Surveillance of drug resistance in tuberculosis in the state of Tamil Nadu. Indian J Tuber 2000; 47: 27-33.
17. Khan J, Islam N, Jafri W. Ajanee N. Drug resistance of mycobacterium tuberculosis in Karachi, Pakistan. Trop Doct 1993; 23:13-4.
18. Irfan S, Hassan Q, Hassan R. Assessment of resistance in multi-drug resistant tuberculosis patients. J Pak Med Assoc 2006; 56: 397-400.
19. Safi MI, Macor G, Habibi GQ. Primary and acquired resistance to TB drugs in Pakistan patients in NWFP. In: Proceeding of the 1st Biennial Conference on Chest Diseases and Tuberculosis. Peshawar: 1994; 55.
20. Isenberg HD. Clinical microbiology procedure hand book. 2nd ed. Vol.2. Washington, D.C: ASM Press, 2004.
21. Wayne LG, Krasnow I. Preparation of tuberculosis susceptibility testing mediums by means of impregnated discs. Am J Public Health 1996; 36:115-7.
22. Haq M, Awan SR. Sensitivity pattern of M. tuberculosis in Lahore, Pakistan. Ann KE Med Coll 2002; 8:190-3.
23. Butt T, Ahmad RN, Kazmi SY, Rafi N. Multi-drug resistant tuberculosis in Northern Pakistan. J Pak Med Assoc 2004; 54: 469-72.